Stay updated with breaking news from Ming Yan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Raymond James assumed coverage on shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) in a research report sent to investors on Tuesday morning, Marketbeat.com reports. The brokerage issued a market perform rating on the stock. Cytek Biosciences Trading Up 0.3 % Shares of CTKB stock opened at $8.90 on Tuesday. The stock has a 50-day […]
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) CTO Ming Yan sold 20,000 shares of the company’s stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $8.76, for a total transaction of $175,200.00. Following the completion of the transaction, the chief technology officer now directly owns 7,830,258 […]
New research finds that promoting strong team leadership, without additional measures to boost company-wide collaboration, could be counter-productive
12 MoUs were signed to deepen collaboration opportunities between Singapore, Vietnam, and the wider region at the Singapore Regional Business Forum on July 7.
Singapore is the 2nd largest investor out of 143 countries and territories investing in Việt Nam with more than 3,200 projects and US$73.4 billion of registered capital.